DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4643-4648

  Laytragoon Lewin, Nongnit ^a,b   Chen, Fu ^b   Castro, Juan ^c   Elmberger, Göran ^d   Rutqvist, Lars Erik ^d   Lewin, Freddi ^d   Turesson, Ingela ^a   Lundgren, Jan ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Swedish Match   (Sweden)

Author keywords

DAPK; DNA content; DNA methylation; HNSCC; P16; RASSF1A

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DNA; GENOMIC DNA; PROTEIN P16; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER CELL; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EVALUATION; DNA CONTENT; DNA METHYLATION; FEMALE; GENE FREQUENCY; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MUCOSA; NASOPHARYNX CARCINOMA; PHARYNX CANCER; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TONSIL CANCER; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 78650235580     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606, 1993.
2. Ii N, Fuwa N, Ando M, Itoh Y, Nomoto Y and Takeda K: DNA ploidy analysis performed prospectively using fresh tumor samples in early glottic carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 52: 415-419, 2002.
3. Forastiere A, Koch W, Trotti A and Sidansky D: Head and neck cancer. N Engl J Med 345: 1890-1900, 2001.
4. Brena RM and Costello JF: Genome-epigenome interactions in cancer. Hum Mol Genet 16 Spec No 1: R96-105, 2007.
5. Fan CY: Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr Oncol Rep 6: 152-161, 2004.
6. Wong TS, Chang HW, Tang KC, Wei WI, Kwong DL, Sham JS, Yuen AP and Kwong YL: High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Clin Cancer Res 8: 433-437, 2002.
7. Supic G, Kozomara R, Brankovic-Magic M, Jovic N and Magic Z: Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 45: 1051-1057, 2009.
8. Su PF, Huang WL, Wu HT, Wu CH, Liu TY and Kao SY: p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. Oral Oncol 46: 734-739, 2010.
9. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG and Belinsky SA: Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958, 2000.
10. Altieri A, Bosetti C, Gallus S, Franceschi S, Dal Maso L, Talamini R, Levi F, Negri E, Rodriguez T and La Vecchia C: Wine, beer and spirits and risk of oral and pharyngeal cancer: a case-control study from Italy and Switzerland. Oral Oncol 40: 904-909, 2004.
11. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, Gupta PC, Hackshaw A, Matos E, Samet J, Sitas F, Smith J, Stayner L, Straif K, Thun MJ, Wichmann HE, Wu AH, Zaridze D, Peto R and Doll R: Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96: 99-106, 2004.
12. Soma T, Kaganoi J, Kawabe A, Kondo K, Imamura M and Shimada Y: Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int J Cancer 119: 1023-1027, 2006.
13. Do KA, Johnson MM, Lee JJ, Wu XF, Dong Q, Hong WK, Khuri FR and Spitz MR: Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101: 2837-2842, 2004.
14. Slaughter DP, Southwick HW and Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968, 1953.
15. Jang SJ, Chiba I, Hirai A, Hong WK and Mao L: Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 20: 2235-2242, 2001.
16. Castro J, Heiden T, Wang N and Tribukait B: Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 14: 793-804, 1993.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
18. Olek A, Oswald J and Walter J: A modified and improved method for bisulphite-based cytosine methylation analysis. Nucleic Acids Res 24: 5064-5066, 1996.
19. Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijder PJ, Snow GB, Leeman CR and Braakhuis BJ: Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 7: 1523-1532, 2001.
20. Sinha P, Bahadur S, Thakar A, Matta A, Macha M, Ralhan R and Gupta SD: Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck 31: 1423-1430, 2009.
21. Ai H, Barrera JE, Meyers AD, Shroyer KR and Varella-Gracia M: Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions. Laryngoscope 111: 1853-1858, 2001.
22. Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK and Dent SY: Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene 22: 8902-8911, 2003.